1. Home
  2. FORTY vs NEO Comparison

FORTY vs NEO Comparison

Compare FORTY & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Formula Systems (1985) Ltd.

FORTY

Formula Systems (1985) Ltd.

HOLD

Current Price

$114.99

Market Cap

1.8B

Sector

Technology

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$19.23

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FORTY
NEO
Founded
1985
2001
Country
Israel
United States
Employees
19337
N/A
Industry
EDP Services
Precision Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.1B
IPO Year
1998
2008

Fundamental Metrics

Financial Performance
Metric
FORTY
NEO
Price
$114.99
$19.23
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
★ $13.38
AVG Volume (30 Days)
2.1K
★ 1.7M
Earning Date
05-21-2026
04-28-2026
Dividend Yield
★ 1.32%
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$10.63
Revenue Next Year
N/A
$9.73
P/E Ratio
$36.65
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$102.01
$7.07
52 Week High
$190.56
$20.05

Technical Indicators

Market Signals
Indicator
FORTY
NEO
Relative Strength Index (RSI) 48.29 59.64
Support Level $109.49 $16.87
Resistance Level $119.68 $19.90
Average True Range (ATR) 1.67 0.80
MACD 0.09 -0.03
Stochastic Oscillator 34.78 70.00

Price Performance

Historical Comparison
FORTY
NEO

About FORTY Formula Systems (1985) Ltd.

Formula Systems (1985) Ltd is an information technology company that is principally engaged through its directly and indirectly held investees in providing software consulting services, selling and marketing computer-based business solutions and hardware products from a wide range of domestic and international manufacturers, as well as developing proprietary software solutions. It delivers solutions in Israel and in numerous countries to customers with complex IT services needs. It designs and implements IT solutions and software systems that improve the productivity of customers' existing IT assets, enable them to effectively manage their operations and reduce their business risks in the face of changing business environments.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: